DL-4-Hydroxy-2-ketoglutarate lithium

Cat. No.: HY-147064 Purity: 93.2%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

DL-4-Hydroxy-2-ketoglutarate lithium is one of the metabolites that is characteristically elevated in the urine of patients with type 3 primary hyperoxaluria (PH3), and it is produced by the accumulation of substrates of mitochondrial 4-hydroxy-2-oxoglutarate aldolase (HOGA). DL-4-Hydroxy-2-ketoglutarate lithium can be used in studies related to PH3.

For research use only. We do not sell to patients.

DL-4-Hydroxy-2-ketoglutarate lithium Chemical Structure

Size	Stock	Quantity
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	Get quote
100 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of DL-4-Hydroxy-2-ketoglutarate lithium:

DL-4-Hydroxy-2-ketoglutarate Get quote

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

View All Endogenous Metabolite Isoform Specific Products:

View All Isoforms

Human Endogenous Metabolite Microbial Metabolite

Biological Activity
Purity & Documentation
References
Customer Review

Description	DL-4-Hydroxy-2-ketoglutarate lithium is one of the metabolites that is characteristically elevated in the urine of patients with type 3 primary hyperoxaluria (PH3), and it is produced by the accumulation of substrates of mitochondrial 4-hydroxy-2-oxoglutarate aldolase (HOGA). DL-4-Hydroxy-2-ketoglutarate lithium can be used in studies related to PH3^[1].
In Vitro	DL-4-Hydroxy-2-ketoglutarate lithium can be further reduced to 2,4-dihydroxyglutarate (DHG) at PH3^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. DL-4-Hydroxy-2-ketoglutarate lithium Related Antibodies
Formula	C₅H₆O₆.xLi
Appearance	Solid
Color	White to off-white
SMILES	O=C(C(CC(C(O)=O)O)=O)O.[x].[Li]
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	-20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Purity & Documentation	Purity: 93.2% Select Batch: Data Sheet (266 KB) SDS (251 KB) COA (247 KB) Handling Instructions (2659 KB)
References	[1]. Clifford-Mobley O, Hewitt L, Rumsby G. Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria. Annals of clinical biochemistry. 2016 Jul;53(Pt 4):485-94. [Content Brief]